Celyad Oncology SA American Depositary Shares
CYAD
CYAD was delisted on the 18th of May, 2023.
8 hedge funds and large institutions have $19.8M invested in Celyad Oncology SA American Depositary Shares in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
20% less funds holding
Funds holding: 10 → 8 (-2)
23% less capital invested
Capital invested by funds: $25.8M → $19.8M (-$5.95M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
+$1.03M |
| 2 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$273K |
| 3 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
+$125K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$12.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$1.09M |
| 2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$534K |
| 3 |
Morgan Stanley
New York
|
-$120K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$71.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RIM
1
RS Investment Management
San Francisco,
California
| $14.5M | +$1.03M | +25,268 | +8% |
|
|
CAM
2
Cormorant Asset Management
Boston,
Massachusetts
| $3.31M | – | – | – |
|
|
DCM
3
DAFNA Capital Management
Los Angeles,
California
| $1.32M | – | – | – |
|
|
4
Zurich Cantonal Bank
Zurich,
Switzerland
| $601K | +$125K | +3,061 | +29% |
|
|
5
Morgan Stanley
New York
| $78K | -$120K | -2,949 | -62% |
|
|
6
UBS Group
Zurich,
Switzerland
| $56K | -$71.2K | -1,744 | -58% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $14K | +$12.8K | +313 | +6,260% |
|
|
VIA
8
Vident Investment Advisory
Alpharetta,
Georgia
| $966 | +$273K | +6,690 | +44% |
|
|
9
Bank of America
Charlotte,
North Carolina
| – | -$1.09M | -19,888 | Closed |
|
|
OMC
10
Old Mission Capital
Chicago,
Illinois
| – | -$534K | -9,776 | Closed |
|
CYAD Hedge Fund Activity: Q1 2016 in Review
8 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Celyad Oncology SA American Depositary Shares (CYAD) for Q1 2016, worth a combined $19.8M — down 23% from $25.8M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CYAD and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was RS Investment Management, adding an estimated $1.03M. The largest seller was Bank of America, exiting entirely with an estimated $1.09M sold.
- 8 institutional investors held Celyad Oncology SA American Depositary Shares (CYAD) as of Q1 2016, down from 10 in Q4 2015.
- Funds reported $19.8M of Celyad Oncology SA American Depositary Shares stock for Q1 2016, down 23% quarter-over-quarter.
- 0 funds opened new Celyad Oncology SA American Depositary Shares positions in Q1 2016 and 2 closed out, a net change of -2 holders.
- The largest Celyad Oncology SA American Depositary Shares buyer in Q1 2016 was RS Investment Management, an estimated $1.03M added.
- The largest Celyad Oncology SA American Depositary Shares seller in Q1 2016 was Bank of America, an estimated $1.09M sold.
Based on aggregated 13F filings for Q1 2016.